The AM-001 study was conducted in response to that FDA request and is also designed to help identify the doses best suited for advancing Aramchol Meglumine into Phase 2 studies. It consists of two ...

(RTTNews) - Galmed Pharmaceuticals Ltd. (GLMD) said that the FDA agreed with its plan to use Aramchol meglumine in its Phase 3 ARMOR study without the need to conduct additional nonclinical and ...

The FDA has agreed with Galmed Pharmaceuticals Ltd's (NASDAQ: GLMD) plan to use Aramchol meglumine (instead of Aramchol free acid) in its Phase 3 ARMOR study without the need for additional ...

CLARISCAN™ (gadoterate meglumine) is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine, and associated tissues ...

Find Meglumine Amidotrizoate combination generic drug prices and manufacturer details. Prices may vary by chemist. Click your brand name for cost information.

Gadoterate Meglumine Injection is a gadolinium-based contrast agent (GBCA) indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues ...

Tafamidis meglumine is a novel, investigational medication designed to treat transthyretin familial amyloid polyneuropathy, or TTR-FAP, in adult patients with symptomatic polyneuropathy to delay ...

Plasma concentrations of flunixin meglumine increased in a dose-dependent manner, but by Hour 8, there was no difference among concentrations at half-dose, 1x, and 2x doses.

Gadoterate Meglumine (Dotatrem) generic is a gadolinium based contrast agent, prescribed for visualization of brain along with magnetic resonance imaging (MRI).

US FDA approves +PLUSPAK™ (polymer bottle) Pharmacy Bulk Package for the gadolinium-based contrast agent, Clariscan™ (gadoterate meglumine) As the only polymer bottle for an MRI contrast agent ...